Evidence map›Paper›PMID 33127012›Full record

ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2020

The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable.

Steven Forsythe, Joshua Cohen, Peter Neumann, Stefano M Bertozzi, Anthony Kinghorn

Abstract readEditorialComment
In one paragraph

Article in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Economic evaluation of programs against COVID-19: A systematic review.International journal of surgery (London, England) · 2021
    Pooled it
  5. Article
  6. Review
  7. Article
  8. Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Article
  9. The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19).Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Steven ForsytheAvenir Health, Glastonbury, CT, USA. Electronic address: sforsythe@avenirhealth.org.
Joshua CohenJoshua P. Cohen Healthcare Analytics, Boston, MA, USA.
Peter NeumannTufts Medical Center, Boston, MA, USA.
Stefano M BertozziUniversity of California Berkeley School of Public Health, Berkeley, CA, USA; Instituto Nacional de Salud Pública, Cuernavaca, México; University of Washington, Seattle, WA, USA.
Anthony KinghornPerinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusCOVID-19COVID-19 Drug TreatmentHumansLopinavirPublic HealthRitonavirSARS-CoV-2LopinavirRitonavir

Identifiers

PMID33127012
PMCPMC7241391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.